Immune system activation via recall antigen effect

The "recall antigen effect" is a process by which the immune system—primarily via memory T cells—mounts a rapid and robust response upon re-exposure to an antigen that has been encountered previously. This effect is central to the principles of vaccination, lasting immunity against many pathogens, and forms part of both protective responses (such as in infection clearance or secondary vaccine responses) and pathological responses (such as autoimmunity when directed against self-antigens). Upon secondary exposure, memory T cells are rapidly activated either by recognizing their cognate antigen presented on MHC molecules ("antigen-dependent activation") or by inflammatory cytokines in the absence of specific antigen stimulation ("bystander activation"). This process results in the immediate production of effector cytokines such as IFN-γ and rapid recruitment of immune cells to sites of challenge, thus enabling a faster and more effective immune defense compared to the initial, naive response. Drugs such as hydroxychloroquine can blunt this response by inhibiting T cell activation and cytokine production in recall settings. In summary, "immune system activation via recall antigen effect" describes a fundamental immunological mechanism but is not a specific molecule, receptor, or conventional pharmacological target. To extract actionable target information for drug development, one would need to specify the cellular or molecular entities (e.g., T cell receptor, specific cytokine receptors) involved in this recall effect.

Other names

Recall antigen responseMemory T cell recall effectT cell memory responseAntigen recall effect

Drugs can suppress or modulate immune recall by interfering with T cell activation, cytokine production, or antigen presentation (e.g., hydroxychloroquine decreases T cell activation and cytokine production upon recall antigen stimulation).